The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Phase I study of pazopanib (PAZ) in combination with abexinostat (ABX) in patients (Pts) with metastatic solid tumors.
Rahul Raj Aggarwal
No relevant relationships to disclose
Jennifer A. Grabowsky
No relevant relationships to disclose
Anne Reinert
No relevant relationships to disclose
Scott Thomas
No relevant relationships to disclose
Paromita Raha
No relevant relationships to disclose
Thierry Marie Jahan
No relevant relationships to disclose
Alain Patrick Algazi
No relevant relationships to disclose
Terence W. Friedlander
No relevant relationships to disclose
Thach-Giao Truong
No relevant relationships to disclose
Saloni Mathur
No relevant relationships to disclose
Pamela N. Munster
Research Funding - GlaxoSmithKline